Assessment of Structural Intolerance and Durability
General Structure Information 2vo1 CTPS1 crystal structure of the synthetase domain of human ctp synthetase 2.8Å AUTH P.KURSULA,S.FLODIN,M.EHN,M.HAMMARSTROM,H.SCHULER,P.NORDLUND,AUTH 2 P.STENMARKTITL STRUCTURE OF THE SYNTHETASE DOMAIN OF HUMAN CTP SYNTHETASE,TITL 2 A TARGET FOR ANTICANCER THERAPY.REF ACTA CRYSTALLOGR.,SECT.F V. 62 613 2006REFN ISSN 1744-3091PMID 16820675DOI 10.1107/S1744309106018136 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons […]
General Structure Information 3h6a ITGB4 structure of the calx-beta domain of integrin beta4 crystallized in the presence of calcium 1.61Å AUTH N.ALONSO-GARCIA,A.INGLES-PRIETO,A.SONNENBERG,AUTH 2 J.M.DE PEREDATITL STRUCTURE OF THE CALX-BETA DOMAIN OF THE INTEGRINTITL 2 BETA4 SUBUNIT: INSIGHTS INTO FUNCTION ANDTITL 3 CATION-INDEPENDENT STABILITYREF ACTA CRYSTALLOGR.,SECT.D V. 65 858 2009REFN ISSN 0907-4449PMID 19622870DOI 10.1107/S0907444909018745 Variant Set […]
General Structure Information 3dre CKB crystal structure of human brain-type creatine kinase 2.2Å AUTH S.M.BONG,J.H.MOON,K.H.NAM,K.S.LEE,Y.M.CHI,K.Y.HWANGTITL STRUCTURAL STUDIES OF HUMAN BRAIN-TYPE CREATINETITL 2 KINASE COMPLEXED WITH THE ADP-MG2+-NO3- -CREATINETITL 3 TRANSITION-STATE ANALOGUE COMPLEXREF FEBS LETT. V. 582 3959 2008REFN ISSN 0014-5793PMID 18977227DOI 10.1016/J.FEBSLET.2008.10.039 Variant Set Distributions Mapped Variants
General Structure Information 3owh NQO2 x-ray structural study of quinone reductase ii inhibition by compounds with micromolar to nanomolar range ic50 values 2.28Å AUTH S.D.PEGAN,M.STURDY,G.FERRY,P.DELAGRANGE,J.A.BOUTIN,AUTH 2 A.D.MESECARTITL X-RAY STRUCTURAL STUDIES OF QUINONE REDUCTASE 2 NANOMOLARTITL 2 RANGE INHIBITORS.REF PROTEIN SCI. V. 20 1182 2011REFN ISSN 0961-8368PMID 21538647DOI 10.1002/PRO.647 Variant Set Distributions Ripley’s K Analysis Plots […]
General Structure Information 3igu NAGA crystal structure of human alpha-n-acetylgalactosaminidase, covalent intermediate 2.15Å AUTH N.E.CLARK,S.C.GARMANTITL THE 1.9 A STRUCTURE OF HUMANTITL 2 ALPHA-N-ACETYLGALACTOSAMINIDASE: THE MOLECULAR BASIS OFTITL 3 SCHINDLER AND KANZAKI DISEASESREF J.MOL.BIOL. V. 393 435 2009REFN ISSN 0022-2836PMID 19683538DOI 10.1016/J.JMB.2009.08.021 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped […]
General Structure Information 3ky9 VAV1 autoinhibited vav1 2.73Å AUTH B.YU,I.R.MARTINS,P.LI,G.K.AMARASINGHE,J.UMETANI,AUTH 2 M.E.FERNANDEZ-ZAPICO,D.D.BILLADEAU,M.MACHIUS,D.R.TOMCHICK,AUTH 3 M.K.ROSENTITL STRUCTURAL AND ENERGETIC MECHANISMS OF COOPERATIVETITL 2 AUTOINHIBITION AND ACTIVATION OF VAV1REF CELL(CAMBRIDGE,MASS.) V. 140 246 2010REFN ISSN 0092-8674PMID 20141838DOI 10.1016/J.CELL.2009.12.033 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants
General Structure Information 2krr NCL solution structure of the rbd1,2 domains from human nucleolin -1.0Å AUTH S.ARUMUGAM,M.C.MILLER,J.MALIEKAL,P.J.BATES,J.O.TRENT,AUTH 2 A.N.LANETITL SOLUTION STRUCTURE OF THE RBD1,2 DOMAINS FROM HUMANTITL 2 NUCLEOLIN.REF J.BIOMOL.NMR V. 47 79 2010REFN ISSN 0925-2738PMID 20376532DOI 10.1007/S10858-010-9412-1 Variant Set Distributions Mapped Variants
General Structure Information 3f7p ITGB4 crystal structure of a complex between integrin beta4 and plectin 2.75Å AUTH J.M.DE PEREDA,M.P.LILLO,A.SONNENBERGTITL STRUCTURAL BASIS OF THE INTERACTION BETWEENTITL 2 INTEGRIN ALPHA6BETA4 AND PLECTIN AT THETITL 3 HEMIDESMOSOMESREF EMBO J. V. 28 1180 2009REFN ISSN 0261-4189PMID 19242489DOI 10.1038/EMBOJ.2009.48 Variant Set Distributions Mapped Variants
General Structure Information 3ii5 BRAF the complex of wild-type b-raf with pyrazolo pyrimidine inhibitor 2.79Å AUTH D.M.BERGER,N.TORRES,M.DUTIA,D.POWELL,G.CISZEWSKI,AUTH 2 A.GOPALSAMY,J.I.LEVIN,K.H.KIM,W.XU,J.WILHELM,Y.HU,AUTH 3 K.COLLINS,L.FELDBERG,S.KIM,E.FROMMER,AUTH 4 D.WOJCIECHOWICZ,R.MALLONTITL NON-HINGE-BINDING PYRAZOLO[1,5-A]PYRIMIDINES ASTITL 2 POTENT B-RAF KINASE INHIBITORS.REF BIOORG.MED.CHEM.LETT. V. 19 6519 2009REFN ISSN 0960-894XPMID 19864136DOI 10.1016/J.BMCL.2009.10.049 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants
General Structure Information 2ror VAV1 solution structure of the vav1 sh2 domain complexed with a tyrosine-phosphorylated peptide from slp76 -1.0Å AUTH T.KASAI,M.TANAKA,S.KOSHIBA,T.KIGAWA,S.YOKOYAMATITL SOLUTION STRUCTURE OF THE VAV1 SH2 DOMAINTITL 2 COMPLEXED WITH A TYROSINE-PHOSPHORYLATED PEPTIDETITL 3 FROM SLP76REF TO BE PUBLISHEDREFN Variant Set Distributions Mapped Variants